Business Wire

Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) announced today financial results for the second quarter and fiscal year-to-date period ended October 31, 2024. "Net sales for the third quarter were $41.6 million, a decrease of $4.1 million, as compared to the same quarter last year. Net income attributable to common stock of $2.5 million was an increase of $0.5 million, or 29%, compared to $1.9 million in the third quarter of 2023. For the nine months ended October 31, 2024, net sales of $113.4 million represent an increase of 3% compared to the nine months ended October 31, 2023. The net income attributable to common stock of $7.2 million was an increase of $5.4 million, or 294%, compared to net income attributable to common stock of $1.8 million in the nine months ended October 31, 2023,” noted President and CEO David Mansfield. “Backlog in the third quarter shows considerable growth and now stands at $114.2 million. This is the equivalent to approximately nine months revenue

LambdaTest, a leading cloud-based unified testing platform has announced the general availability of its reimagined SmartUI screenshot page. This new update is all set to transform visual testing workflows, delivering a seamless, intuitive, and powerful experience tailored to the needs of testers and developers worldwide. The redesigned SmartUI interface introduces groundbreaking enhancements that prioritize user efficiency and precision. From the new pinch-to-zoom functionality for precise screenshot inspection to a streamlined navigation system featuring a side drawer for quick browsing, every detail has been thoughtfully crafted to improve productivity. The refreshed design also offers a cleaner, more spacious layout, ensuring that users can focus on what matters most—their screenshots. Smarter workflows now empower users with an intuitive grouping of related functions, while effortless variant switching simplifies the process of comparing test results. The upgraded keyboard shortcu

Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa; Head Office: Minato-ku, Tokyo), a wholly-owned subsidiary of H.U. Group Holdings, Inc. (Chairman, President and Group CEO: Shigekazu Takeuchi; Head Office: Minato-ku, Tokyo), and Eisai Co., Ltd. (Representative Corporate Officer and CEO: Haruo Naito; Head Office: Bunkyo-ku, Tokyo; hereinafter "Eisai") announced today that they have entered into a memorandum of understanding for the joint research and social implementation of novel blood-based biomarkers in the field of neurodegenerative diseases. Fujirebio and Eisai have been conducting joint research on cerebrospinal fluid biomarkers related to Alzheimer’s disease (AD). The two companies have agreed to move forward with their partnership based on the shared understanding that the development and commercialization of diagnostic methods for neurodegenerative diseases can be accelerated by integrating the long-standing respective expertise of Fujirebio, which has experience in the

Hyatt Hotels Corporation (the “Company” or “Hyatt”) (NYSE: H) today disclosed it has executed an exclusivity agreement with Playa Hotels & Resorts N.V. (“Playa”) (NASDAQ: PLYA) under which Playa has agreed to negotiate exclusively with Hyatt regarding potential strategic alternatives, which may include the acquisition of Playa by Hyatt. Mark S. Hoplamazian, President and Chief Executive Officer of Hyatt, said, "Playa has been a valuable partner for many years, is one of the world’s strongest operators of all-inclusive resorts, and owns a premier portfolio of high-quality, high-end all-inclusive resorts in iconic locations and key markets across the Caribbean and Mexico. Strategic alternatives under consideration could have compelling strategic merit to add new incremental durable fee streams for Hyatt. We remain steadfastly committed to our asset-light business model and if this process continues, we will continue to map out a clear path for an asset-light outcome for any strategic alt

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., announced it will change its Nasdaq ticker symbol to “ONC” on January 2, 2025, reflecting its long-standing commitment to delivering innovative oncology medicines globally. “As we enter our 15th year, changing our ticker to ONC reflects our unwavering commitment to leadership in oncology and mission to deliver transformative medicines to cancer patients worldwide,” said John V. Oyler, Co-Founder, Chairman and CEO at BeiGene. “This milestone inspires pride in all we have accomplished and fuels our excitement for the future as we advance our innovative hematology franchise and solid tumor pipeline, driving meaningful impact for patients everywhere.” The Company’s CUSIP number will remain unchanged. In addition, the Company stock codes and stock names for The Stock Exchange of Hong Kong and the STAR Market of the Shanghai Stock Exchange will not change

ARIA Sensing proudly announces the launch of "Hydrogen," a groundbreaking Ultra-Wideband (UWB) Radar System-On-Chip (SoC) that sets a new industry benchmark as the first to offer 3D beamforming with programmable bandwidth up to 1.8 GHz. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241218452155/en/ Hydrogen, the world's first UWB Radar SoC for 3D detection, of the Italian company ARIA Sensing (Photo: Business Wire) The "Hydrogen" SoC introduces advanced waveforms supporting both single-pulse and pulse-compression capabilities, delivering unparalleled precision in radar sensing applications. Equipped with two integrated RISC-V microprocessors, the chip ensures robust performance and flexibility for a variety of use cases. Key features of "Hydrogen" include: 4Tx and 4Rx UWB channels: Allowing flexible and scalable array configurations for optimized 3D imaging and radar detection. Advanced 3D Beamforming: Providing accurate de

The 2024 Global Brand Cultural Event hosted by Kweichow Moutai Group recently concluded successfully in Italy. Leveraging liquor as a cultural bridge between East and West, the event charted new pathways and milestones for Chinese brands, exemplified by Kweichow Moutai Group, in their global outreach. It also fostered deeper cultural exchange and mutual understanding between China and Italy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241222852417/en/ Gao Shan introduced Moutai to the guests at the event in Rome. (Photo: Business Wire) As part of the event, Moutai organized two grand themed tasting dinners in Milan and Rome. Gao Shan, Chairman of the Labor Union of Kweichow Moutai Distillery (Group) Co., Ltd., highlighted Italy's longstanding support in Moutai’s international journey, noting that the brand has been exported to Italy since the 1970s. Quoting Italian President Sergio Mattarella during his visit to China, Ga

On December 9th, the exhibition “Longevity in the Tao of Chrysanthemum: The Artistic World of Qi Baishi,” supported by Kweichow Moutai Group, opened at the Athens University History Museum. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241221429801/en/ Gao Shan(R3), and Petros Tatoulis(R2), took a group photo with other guests at the opening ceremony of the exhibition. (Photo: Business Wire) Featuring the works of Qi Baishi, a renowned Chinese painter, the exhibition highlights the unique charm of traditional Chinese culture for Western audiences, while advancing cultural exchange and mutual understanding between China and Greece. Gao Shan, Chairman of the Labor Union at Kweichow Moutai Distillery (Group) Co., Ltd., remarked on the significance of the event, saying, “Qi Baishi employed distinctive Eastern painting techniques to convey the Chinese perspective of the world. Athens, a city celebrated for its great masters and

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai

Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa

TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi

On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e

Global technology corporation FPT recently secured the 2024 EcoVadis Gold Rating for its overseas branch in Germany, positioning the company among the top 5 percent of businesses globally for sustainability practices. This recognition reaffirms the company’s unwavering commitment to corporate responsibility and sustainable development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241220491600/en/ (Graphic: Business Wire) EcoVadis, a leading global platform for sustainability assessments, evaluates businesses across four critical areas: environmental impact, labor and human rights, ethics, and sustainable procurement. Since its founding in 2007, EcoVadis has created a benchmark for over 130,000 companies across 220 industries and 180 countries, offering a robust framework for assessing and comparing corporate sustainability performance. FPT attained an overall score of 79/100, with 80/100 in Environment, Labor & Human Right

IFF (NYSE: IFF) today unveiled the next phase in the evolution of its Board of Directors, aimed at bolstering the company's long-term strategic vision and driving profitable market share growth. New Board Chair: Kevin O’Byrne—an experienced IFF board member and chair of Centrica plc—will become Board Chair at the 2025 Annual Shareholder Meeting. O’Byrne will succeed Roger W. Ferguson, Jr. who has served as Chair since 2022. Ferguson notified IFF of his intent to not stand for reelection at the 2025 Annual Shareholder Meeting after 14 years of distinguished service. Board Appointments: Cynthia Jamison, Dr. Mehmood Khan and Vincent Intrieri will join the Board of Directors effective Jan. 1, 2025. Intrieri’s appointment is at the request of Icahn Capital LP pursuant to the Cooperation agreement. He replaces Gary Hu, who will step down from the IFF Board on Dec. 31, 2024. Board Retirements: Christina Gold and John Davidson have announced their plans to not stand for reelection at the 2025

Egress, a KnowBe4 company, the first provider of adaptive AI-enabled email security, today announced it has been recognized as a Leader in 2024 Gartner Magic Quadrant for Email Security Platforms. Egress has been recognized for its Ability to Execute and Completeness of Vision in this report. We see a recent rise of advanced technology to address sophisticated inbound phishing attacks and behavior-led outbound data breaches has driven significant innovation in email security. Egress is proud to be a Leader in the first Magic Quadrant for Email Security Platforms. We believe Egress has architected an adaptive AI-enabled platform to detect the full spectrum of inbound and outbound threats. Egress believes we are recognized because of our: Advanced AI-enabled detection to mitigate the full spectrum of threats Holistic understanding of human risk generated through deep per-user behavioral analytics and threat intelligence, used to deliver personalized security at the point of risk Offering

Aster DM Healthcare has announced the fourth edition of the Aster Guardians Global Nursing Award, inviting nurses worldwide to apply for the prestigious USD 250,000 prize. The award recognizes exceptional contributions to healthcare, celebrating the dedication and impact of nurses across diverse areas of practice. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241219780915/en/ Aster Guardians Global Nursing Award worth USD $250,000 (Photo: AETOSWire) Registered nurses can submit their applications via www.asterguardians.com, showcasing their work in Patient Care, Nursing Leadership, Nursing Education, Social or Community Service, or Research Innovation & Entrepreneurship in Healthcare. Applicants may choose one Primary and up to two Secondary areas of contribution to highlight their multifaceted efforts. The evaluation process will be meticulously overseen by an independent jury and supported by Ernst & Young LLP (EY). Follo

ProAmpac, a leader in flexible packaging and material science, is proud to announce its ProActive Recyclable® RP-1000 Paper Series as a finalist in two categories at the prestigious PAC Global Awards 2025. These recognitions underscore ProAmpac’s dedication to advancing sustainable and technically sophisticated packaging solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241219376860/en/ M&S Organic White Potatoes (Photo: Business Wire) The company’s ProActive Recyclable® RP-1000 Paper Series, used in Marks & Spencer's Select Farms Organic potato range, has earned nominations in the Sustainability and Technical Design categories. This solution combines a fully curbside recyclable paper structure with excellent seal performance to deliver a premium sustainable solution with vibrant printability. “At ProAmpac, our customers are at the center of our product innovations,” said Hesam Tabatabaei, ProAmpac’s senior vice pres

Nomios, a leading European cybersecurity player, has announced the integration of Qevlar's generative AI within its Security Operations Centers (SOCs). Following a period of targeted evaluation, which delivered a marked improvement in the teams' efficiency, the Qevlar AI solution is now fully operational and integrated into Nomios' seven managed SOCs. Now, all 67 European clients can benefit at no extra cost. Since opening its Modern SOC four years ago, Nomios has concentrated on expertise and customization to meet its clients' needs. Nomios SOCs were designed from the outset without a level 1 analyst, relying on automation (SOAR & playbooks) to offer extremely rapid, high-quality detection, sorting and analysis times. After having tested the Qevlar AI solution for its own needs (Nomios IS), Nomios became the first European managed SOC operator to put the French start-up's advanced technology into production and to make it available to its current and future clients. Eric Bohec, Group

Onego Bio, a Finnish-U.S. food ingredient company, announced the submission of its Generally Recognized as Safe (GRAS) notification to the U.S. Food and Drug Administration (FDA) for its non-animal ovalbumin, produced through precision fermentation using Trichoderma reesei, and branded as Bioalbumen®. This milestone marks a critical step toward bringing the first non-animal egg protein with an amino acid sequence identical to the natural protein, to the global food market. Ovalbumin, the primary protein found in egg white, is known for its exceptional nutritional, functional, and performance properties. Onego Bio's breakthrough Bioalbumen® offers a sustainable solution, leveraging precision fermentation to produce ovalbumin outside of the poultry supply chain. This ingredient was created to address supply chain challenges of the $300B global egg market. “Our GRAS filing marks a significant milestone for Onego Bio, reinforcing our commitment to building a more resilient supply chain and